Phospholipid-chitosan hybrid nanoliposomes promoting cell entry for drug delivery against cervical cancer.

MLA

Saesoo, Somsak, et al. “Phospholipid-Chitosan Hybrid Nanoliposomes Promoting Cell Entry for Drug Delivery against Cervical Cancer.” Journal of Colloid and Interface Science, vol. 480, Oct. 2016, pp. 240–48. EBSCOhost, https://doi.org/10.1016/j.jcis.2016.06.071.

APA

Saesoo, S., Bunthot, S., Sajomsang, W., Gonil, P., Phunpee, S., Songkhum, P., Laohhasurayotin, K., Wutikhun, T., Yata, T., Ruktanonchai, U. R., & Saengkrit, N. (2016). Phospholipid-chitosan hybrid nanoliposomes promoting cell entry for drug delivery against cervical cancer. Journal of Colloid and Interface Science, 480, 240–248. https://doi.org/10.1016/j.jcis.2016.06.071

Chicago

Saesoo, Somsak, Suphawadee Bunthot, Warayuth Sajomsang, Pattarapond Gonil, Sarunya Phunpee, Patsaya Songkhum, Kritapas Laohhasurayotin, et al. 2016. “Phospholipid-Chitosan Hybrid Nanoliposomes Promoting Cell Entry for Drug Delivery against Cervical Cancer.” Journal of Colloid and Interface Science 480 (October): 240–48. doi:10.1016/j.jcis.2016.06.071.